Lender Requests to Convert Loan to MindBio Shares
VANCOUVER, BC / ACCESSWIRE / April 16, 2024 / MindBio Therapeutics Corp. (CSE:MBIO)(Frankfurt:WF6), (the "Company" or "MindBio") is pleased to...
VANCOUVER, BC / ACCESSWIRE / April 16, 2024 / MindBio Therapeutics Corp. (CSE:MBIO)(Frankfurt:WF6), (the "Company" or "MindBio") is pleased to...
Toronto, Ontario--(Newsfile Corp. - April 16, 2024) - AlayaCare, a leading home-based care technology platform, will be participating in the...
The health IT company took the top spot in 10 key performance indicators in the independent user survey that included...
Kiani’s Speech on Wednesday, at the 6th Global Ministerial Summit on Patient Safety, Will Explore How AI-Based Medical Solutions Can...
ATLANTA--(BUSINESS WIRE)--#AIInHealthcare--The US healthcare industry loses billions annually due to denied claims, predominantly caused by manual coding errors. Neural Wave...
Radiologists at Muhimbili National Hospital, part of the Muhimbili University of Health and Sciences and the largest public hospital in...
Initial, interim long-term data from the ongoing ralinepag phase 3 ADVANCE EXTENSION open label study to be presented at a...
Jupiter, Florida--(Newsfile Corp. - April 16, 2024) - Healing Realty Trust ("HRT" or the "Company"), formerly known as Healing Commercial...
80,000 Square Foot (7,500 Square Meter) Property includes 12 GMP Clean Rooms, Laboratory and Office space, and can accommodate expanded...
Cannabix has developed an autonomous alcohol breathalyzer screening device for employersVANCOUVER, British Columbia, April 16, 2024 (GLOBE NEWSWIRE) -- Cannabix...
Ongoing efforts to build a robust global patent estate for a growing pipeline targeting high-value indications in need of innovation...
Telomir-1 elongates telomere caps on human normal embryonic fibroblast cells by stimulating the enzyme telomerase that protects the DNA and...
Expansion offers the potential for continuous, discreet and simplified epidural glucose monitoring solutions for patients with Painful Diabetic Neuropathy Rutherford,...
ZUG, Switzerland and SAN JUAN, Puerto Rico and TORONTO, April 16, 2024 (GLOBE NEWSWIRE) -- Aphaia Pharma, a clinical-stage company...
- Study results confirm potential utility of targeting lysosomal genes to treat neurodegenerative diseases, including Alzheimer’s disease -SOUTH SAN FRANCISCO,...
VANCOUVER, British Columbia, April 16, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neuroscience-focused biopharmaceutical company, announced two oral...
Company continues advancing ongoing development of targeted therapies for ulcerative colitis (UC) Carlsbad, CA, April 16, 2024 (GLOBE NEWSWIRE) -- Palisade...
Disruptive Biotech Firm Appoints Public Markets Veteran Nelson Grist as its Chief Executive Officer and Future Member of its Board...
Leveraging ProPhase Labs’ AI platform, massive genomics database and patented esophageal cancer insights for Antibody Drug Conjugates development. Garden City,...
SAN FRANCISCO, April 16, 2024 (GLOBE NEWSWIRE) -- Excision BioTherapeutics, Inc. (“Excision”, the “Company”), a clinical-stage biotechnology company developing CRISPR-based...